Cardiac Markers: A Guide to Laboratory Testing for Heart Health

Key takeaways

• Cardiac markers are blood substances that can rise when heart muscle is injured or under stress.
• Troponin is the preferred marker for detecting heart muscle injury in most clinical settings.
• BNP and NT-proBNP are used to evaluate heart failure and fluid overload.
• Results are interpreted alongside symptoms, ECG findings, and imaging, not in isolation.
• Timing of blood draws matters because some markers rise and fall over different time frames.
• No single test diagnoses a heart attack; clinicians combine multiple types of information.

What Are Cardiac Markers?

Cardiac markers are proteins, enzymes, or hormones that can be measured in the blood and that change in relation to heart muscle injury, strain, or hemodynamic stress. When heart muscle cells are damaged, their contents can leak into the bloodstream, where they become detectable on laboratory testing. Other markers reflect stretching or pressure within the heart rather than cell death.

Different markers have different patterns. Some rise quickly after an injury and return to normal within hours or days, while others rise more slowly and remain elevated longer. Understanding these patterns helps clinicians choose which test to order and when to repeat it. Testing is typically ordered as part of a broader evaluation that includes a history, physical examination, and electrocardiogram.

Common Cardiac Markers and What They Measure

Troponin is a regulatory protein found in heart muscle. Cardiac troponin tests, often called high-sensitivity troponin assays, detect small amounts of this protein in the blood. Because troponin is highly specific to heart muscle, it is the preferred biomarker for evaluating suspected heart muscle injury in most emergency and inpatient settings. Levels can also be elevated in conditions that strain the heart, such as kidney disease, severe infections, or rapid heart rhythms.

BNP and NT-proBNP are released when heart muscle is stretched, as can occur in heart failure. They are used to help diagnose heart failure, assess severity, and monitor response to treatment. Creatine kinase MB (CK-MB) was once widely used for detecting heart muscle injury but has largely been replaced by troponin. Myoglobin rises very early after muscle injury but is not specific to the heart, so it is used less often today. Some laboratories also measure inflammatory markers such as C-reactive protein, though these are not specific to the heart.

How Cardiac Marker Testing Is Performed

Cardiac marker testing requires a blood sample, usually drawn from a vein in the arm. In urgent settings, the sample is sent to a laboratory for rapid analysis, and results may be available within an hour. For serial testing, blood is drawn at set intervals, often at presentation and again a few hours later, to look for a rising or falling pattern that can indicate acute injury.

Timing is important. Troponin can take a few hours to become detectable after the onset of injury, so a single early normal result may not exclude a problem. Clinicians often use serial measurements combined with the timing of symptoms. Results are reported with reference ranges that vary by laboratory and assay, so values should always be interpreted using the range provided by the testing lab.

Interpreting Results and Their Limits

A cardiac marker result is one piece of a larger clinical picture. An elevated troponin can indicate heart muscle injury, but it does not by itself identify the cause. Clinicians consider symptoms, ECG changes, imaging such as echocardiography, and the pattern of marker changes over time. Similarly, BNP levels can support a diagnosis of heart failure but can be influenced by age, kidney function, and other conditions.

Cardiac markers also have limitations. Levels can be elevated for reasons unrelated to a heart attack, including kidney impairment, extreme exercise, and other acute illnesses. Conversely, normal results do not always rule out a cardiac problem, especially if testing occurs too early. Because of these nuances, results should be discussed with a qualified healthcare professional who can interpret them in context.

Frequently Asked Questions

Sources

• MedlinePlus: Troponin Test
• MedlinePlus: BNP and NT-proBNP Test
• National Heart, Lung, and Blood Institute: Heart Tests
• Centers for Disease Control and Prevention: Heart Disease
• Mayo Clinic: Heart Disease Diagnosis